Interphex
Ropack Expands Capabilities
Invests in state-of-the-art equipment, line automation, enhanced proprietary production planning methods and a new analytical laboratory.
As Ropack approaches its 50th year in business, it is significantly expanding its overall capabilities. Through strategic capital investments in state-of-the-art equipment, line automation, enhanced proprietary production planning methods and the establishment of a new analytical laboratory (chemistry and microbiology testing), Ropack has substantially increased capacity across all its technologies.
Pharmaceutical and Nutraceutical Companies seeking increased capacity and expertise in outsourcing solid oral dose products across a variety of therapeutic areas—from anti-obesity GLP-1 receptor agonists to CNS, GI, Pain Management, OTC, Nutraceutical products and beyond— can partner with Ropack for technology transfer services and innovative solutions, including:
- Powder blending
- Encapsulation
- Direct compression of tablets and caplets
- Filling of HDPE bottles of all shapes and barrier materials with 2D printing and inspection (with or without serialization)
- Flip-top and screw-top vials for hygroscopic and sensitive products
- Thermoform and cold-form blister packaging, with 2D printing and inspection
- Stick pack and sachet filling, with 2D printing and inspection
- Comprehensive secondary and tertiary packaging operations, including kit assembly, with 2D printing and inspection (with or without serialization)
- In country clinical distribution services, including over-encapsulation and randomization
In addition to its expanded capabilities, Ropack is committed to shaping the next 50 years of its business with sustainable initiatives. A key focus is the evolution of blister packaging using the latest sustainable materials.
